The world's oceans cover more than 70% of the Earth's surface and are home to an estimated 700,000 to one million species — the vast majority of which remain scientifically unexplored. Within this vast biological frontier lies what many scientists now believe to be the next great revolution in medicine, materials science and environmental management.
At Virgotech we have been at the forefront of marine biotechnology research for over two decades — and what we are witnessing today is nothing short of extraordinary.
Marine organisms have evolved under conditions of extreme pressure, temperature, salinity and competition over hundreds of millions of years. This evolutionary pressure has produced compounds and biological mechanisms of extraordinary sophistication — many of which have direct applications in human medicine, environmental remediation and industrial processes.
Among the most promising areas of marine biotechnology research currently being pursued at Virgotech are marine-derived antibiotics, biopolymers from marine waste and ocean-based bioremediation.
Marine microorganisms — particularly bacteria found in deep-sea hydrothermal vent environments — have been shown to produce antibiotic compounds effective against drug-resistant bacterial strains that have defeated conventional treatments. Our research team is currently isolating and characterizing several promising candidate compounds.
Meanwhile our marine biomaterials program — which focuses on repurposing waste from fisheries and aquaculture into fertilizers and novel biopolymers — is already delivering commercially viable products to clients in the agricultural and packaging sectors.
The future of marine biotechnology is bright and Virgotech is committed to remaining at its cutting edge — simulating and harnessing the power of the ocean for the benefit of humanity.
Virgotech Biotechnology
Connect with our team to learn more about our biotechnology solutions and research programs.
